Stockreport

Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA

NEURALSTEM  (CUR) 
NASDAQ:AMEX Investor Relations: investor.neuralstem.com
PDF GERMANTOWN, Md., Oct. 31, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (Nasdaq: CUR), a clinical-stage biopharmaceutical company developing novel treatments for diseases [Read more]